In this episode, Dr. Pearl who led the Permanente Medical Group for almost two decades and is the author of a new book on physician culture, reveals how doctors may be unintentionally harming the healthcare system and how that culture needs to be transformed for the betterment of all involved.
Medcity Pivot Podcast
It’s important for clinicians to consider AI recommendations with a critical eye, the same as they would for any other test, said Dr. Erich Huang, Director of Duke Forge. In our latest podcast episode, he spells out the stakes for implementing algorithms in healthcare, which can potentially affect thousands of patients.
Livongo’s founder has created a new care navigation venture because he believes that both the experience that people undergo as they look for care and the level of risk that vendors are willing to take when they work with self-insured employers leave much to be desired.
Ho Sung Cho, senior vice president of Biodiscovery Therapeutics at Bristol Myers Squibb, talks about lessons learned from drug discovery, recent success tied to Covid-19, and how the company is leveraging its expertise in protein degradation to develop novel therapies for blood cancers, solid tumors and other important therapeutic areas.
Slovenski left his perch atop Walmart Health last year to join a diagnostics company that has been around since 2005. In our latest podcast episode, he talks about the future of the diagnostics industry and his ambitions for a wholesale reinvention.
Dr. Ami Bhatt, a cardiologist at Mass General Hospital, says there are situations in which virtual care alone may work better than in-person care, but it would be a mistake to pit in-person care against virtual care.
In this episode of the MedCity Pivot podcast, Daniel Levner, co-founder and chairman of the scientific advisory board at Sight Diagnostics, explains how computer vision is changing blood diagnostics.
Expanding Medicaid and then adjusting Medicare coverage based on financial and income status would be one way to improve healthcare policy and make sure that more Americans have healthcare when they need it.
Bari Kowal, vice president of global clinical operations at Regeneron Pharmaceuticals, gives an update on the clinical trials ongoing to develop drugs to fight Covid-19 and provides insights on how the clinical trials landscape and pharma overall must change in the next episode of MedCity Pivot Podcast.